138 related articles for article (PubMed ID: 6335891)
21. T and B cells in borderline (BB) leprosy.
Biggins T; Narayanan RB; Ramu G; Desikan KV
Indian J Lepr; 1988 Jan; 60(1):21-5. PubMed ID: 3264563
[TBL] [Abstract][Full Text] [Related]
22. Immunologic aspects of leprosy.
Ashamalla L
Int J Dermatol; 1986 Sep; 25(7):452-5. PubMed ID: 3095252
[TBL] [Abstract][Full Text] [Related]
23. Studies on T cell subsets and functions in leprosy.
Bach MA; Chatenoud L; Wallach D; Phan Dinh Tuy F; Cottenot F
Clin Exp Immunol; 1981 Jun; 44(3):491-500. PubMed ID: 6459897
[TBL] [Abstract][Full Text] [Related]
24. Influence of fetal calf serum on the results of the E rosette test.
Naess A
Acta Pathol Microbiol Immunol Scand C; 1983 Feb; 91(1):77-9. PubMed ID: 6869018
[TBL] [Abstract][Full Text] [Related]
25. Phytohaemagglutinin (PHA)-induced transformation of peripheral blood-lymphocytes in leprosy patients.
Ghei SK; Sengupta U; Ramu G
Lepr India; 1980 Apr; 52(2):223-8. PubMed ID: 6969819
[TBL] [Abstract][Full Text] [Related]
26. The effect of delayed addition of antigen and 'E' rosetting on the proliferative response to mycobacterial antigens of peripheral blood lymphocytes from normal individuals or from patients with tuberculosis or leprosy.
Bahr GM; Rook GA; Stanford JL; Lydyard PM; Bryceson AD
Immunology; 1981 Nov; 44(3):585-91. PubMed ID: 7033116
[TBL] [Abstract][Full Text] [Related]
27. T cell subsets in leprosy lesions: in situ characterization using monoclonal antibodies.
Narayanan RB; Bhutani LK; Sharma AK; Nath I
Clin Exp Immunol; 1983 Mar; 51(3):421-9. PubMed ID: 6342880
[TBL] [Abstract][Full Text] [Related]
28. Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders.
Thole JE; Janson AA; Kifle A; Howe RC; McLean K; Nurilygn A; Filley E; Shannon EJ; Bulla GJ; Hermans J
Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):369-80. PubMed ID: 7594920
[TBL] [Abstract][Full Text] [Related]
29. T-cell depletion of spleen in patients with longstanding lepromatous leprosy.
Mathias C; Chacko CJ; Sundar Rao PS; Job CK
Lepr India; 1980 Jul; 52(3):366-73. PubMed ID: 6970854
[TBL] [Abstract][Full Text] [Related]
30. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
[TBL] [Abstract][Full Text] [Related]
31. A search for thymie (T) lymphocyte inhibitory factors in sarcoid sera.
Price CD; Davies B; Williams WJ
Z Erkr Atmungsorgane; 1977 Aug; 149(2):253-8. PubMed ID: 305692
[TBL] [Abstract][Full Text] [Related]
32. Prognostic evaluation of cell mediated immunity in leprosy and correlation with clinicopathological status of leprosy patients.
Aziz M; Malik A; Abbas SM; Vasenwala S; Kalam A
Indian J Pathol Microbiol; 1996 Jan; 39(1):5-12. PubMed ID: 8755125
[TBL] [Abstract][Full Text] [Related]
33. Absence of inhibitory effect of leprosy sera upon normal E rosetting.
Geller M; Flaherty DK; Azulay RD; Surfus JE
Int J Dermatol; 1978 Oct; 17(8):649-51. PubMed ID: 310428
[TBL] [Abstract][Full Text] [Related]
34. Analysis of T-lymphocyte subpopulations in juvenile-onset diabetics.
Müller R; Kolb H; Kuschak D; Jörgens V; Gries FA
Clin Exp Immunol; 1980 Jan; 39(1):130-5. PubMed ID: 6966986
[TBL] [Abstract][Full Text] [Related]
35. Effect of bovine horn cancer serum on E-rosetting capacity of peripheral blood lymphocytes from normal unaffected animals.
Dhingra VK; Gupta RK; Sadana JR
Res Vet Sci; 1982 Sep; 33(2):138-41. PubMed ID: 6983095
[TBL] [Abstract][Full Text] [Related]
36. In vitro proliferative response to M. leprae and PPD of isolated T cell subsets from leprosy patients.
Bach MA; Wallach D; Flageul B; Cottenot F
Clin Exp Immunol; 1983 Apr; 52(1):107-14. PubMed ID: 6345031
[TBL] [Abstract][Full Text] [Related]
37. E rosetting lymphocytes in inflammatory bowel disease. An analysis using monoclonal antibodies.
Makiyama K; Selby WS; Jewell DP
Clin Exp Immunol; 1983 May; 52(2):350-4. PubMed ID: 6602677
[TBL] [Abstract][Full Text] [Related]
38. In vitro enhancement of peripheral blood mononuclear cell natural killer activity following short term incubation with fetal calf serum.
Lauer SJ; Finlan J; Borella LD; Piaskowski VD; Casper JT
J Clin Lab Immunol; 1983 Oct; 12(2):105-10. PubMed ID: 6606047
[TBL] [Abstract][Full Text] [Related]
39. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
Mustafa AS
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
[TBL] [Abstract][Full Text] [Related]
40. Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy.
Nath I; Sathish M; Jayaraman T; Bhutani LK; Sharma AK
Clin Exp Immunol; 1984 Dec; 58(3):522-30. PubMed ID: 6391762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
